Adaptimmune Therapeutics Plc (ADAPY)
0.03
+0.01
(+67.60%)
USD |
OTCM |
Nov 11, 16:00
Adaptimmune Therapeutics Market Cap : 7.952M for Nov. 11, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 7.952M |
| November 10, 2026 | 4.744M |
| November 09, 2026 | 6.494M |
| November 06, 2026 | 5.274M |
| November 05, 2026 | 5.010M |
| November 04, 2026 | 5.301M |
| November 03, 2026 | 6.626M |
| November 02, 2026 | 7.103M |
| October 30, 2026 | 6.096M |
| October 29, 2026 | 6.918M |
| October 28, 2026 | 7.607M |
| October 27, 2026 | 7.66M |
| October 26, 2026 | 6.653M |
| October 23, 2026 | 7.952M |
| October 22, 2026 | 6.626M |
| October 21, 2026 | 8.482M |
| October 20, 2026 | 8.614M |
| October 19, 2026 | 9.277M |
| October 16, 2026 | 8.482M |
| October 15, 2026 | 8.826M |
| October 14, 2026 | 7.952M |
| October 13, 2026 | 7.554M |
| October 12, 2026 | 7.952M |
| October 09, 2026 | 7.952M |
| October 08, 2026 | 7.421M |
| Date | Value |
|---|---|
| October 07, 2026 | 7.395M |
| October 06, 2026 | 7.686M |
| October 05, 2026 | 7.952M |
| October 02, 2026 | 9.807M |
| October 01, 2026 | 10.07M |
| September 30, 2026 | 10.07M |
| September 29, 2026 | 6.891M |
| September 28, 2026 | 7.103M |
| September 25, 2026 | 6.759M |
| September 24, 2026 | 6.096M |
| September 23, 2026 | 6.891M |
| September 22, 2026 | 6.971M |
| September 21, 2026 | 7.050M |
| September 18, 2026 | 5.964M |
| September 17, 2026 | 6.096M |
| September 16, 2026 | 6.626M |
| September 15, 2026 | 6.626M |
| September 14, 2026 | 6.361M |
| September 11, 2026 | 6.003M |
| September 10, 2026 | 6.136M |
| September 09, 2026 | 6.626M |
| September 08, 2026 | 6.891M |
| September 04, 2026 | 7.103M |
| September 03, 2026 | 6.891M |
| September 02, 2026 | 6.626M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kiniksa Pharmaceuticals International Plc | 7.516B |
| Autolus Therapeutics Plc | 328.93M |
| Bicycle Therapeutics Plc | 186.55M |
| Scancell Holdings Plc | 119.34M |
| Roivant Sciences Ltd. | 30.29B |
Market Cap Related Metrics
| Price | 0.03 |